文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

COVID-19大流行第一年美国急诊科心脏骤停管理

Cardiac Arrest Management in United States Emergency Departments During the First Year of the COVID-19 Pandemic, 2020.
PubMed 文献 · Ann Emerg Med · 2025-04-02
一句话结论多中心前瞻性队列显示,2020年大流行早期急诊科对疑似与不疑似COVID-19的心脏骤停患者,胸外按压、除颤/复律及未恢复自主循环比例均相似。

该研究为20个地理分布不同的美国学术急诊科参与的多中心前瞻性观察性队列,纳入2020年5月至12月1,143例心脏骤停事件,由437名参与医生或高级实践提供者管理。183例(16%)疑似COVID-19,其中34例(19%)实验室确诊,149例(81%)依据临床印象疑似。疑似与不疑似患者接受胸外按压比例(16.4% vs 13.5%,差值2.9%,95%CI -3.3至9.0)和除颤/复律比例(7.1% vs 5.3%,差值1.8%,95%CI -2.5至6.1)相似;未恢复自主循环比例也相似(62.3% vs 67.1%,差值-4.8%,95%CI -12.7至3.2)。疑似患者更常使用全屏障个人防护装备(61.8% vs 54.9%,差值8.1%,95%CI 0.7%至15.5)。

要点

  • 疑似与不疑似COVID-19的心脏骤停患者接受胸外按压比例相似(16.4% vs 13.5%,差值2.9%,95%CI -3.3至9.0)。
  • 两组除颤/复律比例相似(7.1% vs 5.3%,差值1.8%,95%CI -2.5至6.1)。
  • 未恢复自主循环比例两组相似(62.3% vs 67.1%,差值-4.8%,95%CI -12.7至3.2)。
  • 疑似COVID-19患者更常使用全屏障个人防护装备(61.8% vs 54.9%,差值8.1%,95%CI 0.7%至15.5)。
  • 183例(16%)疑似COVID-19中,34例(19%)实验室确诊,149例(81%)依据临床印象疑似。

适用人群与场景

  • 2020年5月至2020年12月在美国20个地理分布不同的学术急诊科就诊的心脏骤停患者。
  • 纳入疑似与不疑似COVID-19的心脏骤停事件,共1,143例,由437名参与医生或高级实践提供者管理。

研究设计与关键结果

  • 研究类型:多中心前瞻性观察性队列研究,20个美国学术急诊科,2020年5月至2020年12月,1,143例心脏骤停事件。
  • 183例(16%)疑似COVID-19,其中34例(19%)实验室确诊,149例(81%)依据临床印象疑似。
  • 胸外按压:疑似组16.4% vs 不疑似组13.5%,差值2.9%(95%CI -3.3至9.0)。
  • 除颤/复律:疑似组7.1% vs 不疑似组5.3%,差值1.8%(95%CI -2.5至6.1)。
  • 未恢复自主循环:疑似组62.3% vs 不疑似组67.1%,差值-4.8%(95%CI -12.7至3.2)。
  • 全屏障个人防护装备使用:疑似组61.8% vs 不疑似组54.9%,差值8.1%(95%CI 0.7%至15.5)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:尽管大流行早期对急诊人员存在潜在暴露风险,疑似与不疑似COVID-19的心脏骤停患者的管理相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: The COVID-19 pandemic posed exposure risk for health care personnel, potentially affecting the care for patients with cardiac arrest. We compare emergency department (ED) cardiac arrest management in patients who were suspected and not suspected of COVID-19 early in the pandemic in 2020.

METHODS: This was a multicenter prospective observational cohort study of cardiac arrest patients conducted at 20 geographically diverse United States academic EDs from May 2020 to December 2020. We used percentage point differences, proportion tests, and 95% confidence intervals (CIs) to analyze cardiac arrest management-chest compressions, defibrillation/cardioversion, airway management-by suspected COVID-19 status.

RESULTS: We identified 1,143 cardiac arrest events managed by 437 participating physicians or advanced practice providers. Of 183 (16%) patients suspected of COVID-19, 34 (19%) had laboratory confirmation, whereas 149 (81%) were suspected by clinical impression. Comparing COVID-19 suspected and not suspected patients, proportions who received chest compressions (16.4% versus 13.5%, respectively; difference 2.9% [95% CI, -3.3 to 9.0]) and defibrillation/cardioversion (7.1% versus 5.3%, respectively; difference 1.8% [95% CI -2.5 to 6.1]) were similar. The proportion not achieving return of spontaneous circulations was also similar between the groups (62.3% versus 67.1%, respectively, difference -4.8% [95% CI -12.7 to 3.2]). Full-barrier personal protective equipment was used more often in those suspected of COVID-19 (61.8% versus 54.9%, respectively, difference of 8.1% [95% CI 0.7% to 15.5]).

CONCLUSION: Despite potential exposure risks to ED personnel early in the pandemic, cardiac arrest management of patients suspected and not suspected of COVID-19 was similar.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Torres JR, Paxton JH, León ES, et al. Cardiac Arrest Management in United States Emergency Departments During the First Year of the COVID-19 Pandemic, 2020. Ann Emerg Med. 2025. PMID: 40172505. doi:10.1016/j.annemergmed.2025.02.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。